Premium Information is available for this item - Upgrade for $1 a day
6505-01-067-2813
Amino Acids Injection With Electrolytes
6505010672813 010672813 F0338062703 TRAVASOL M NDC00338-0627-03
INC: 33823 Amino Acids Injection With Electrolytes
January 2023
4
Marketplace 6505-01-067-2813
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-067-2813 5+ Documents (More...)
RQST NE Updated Every Day 6505-01-067-2813 RQST Updated Every Day 6505-01-067-2813 RQST NE Related Documents
6505-01-067-2813 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-067-2813
www.nsnlookup.com /fsg-65/fsc-6505/es 6505-33-104-0909 6505-33-190-0486 TRAVASOL M Acids 6505-33-104-
Acids 6505-33-104-0909 33-190-0486 https/ TRAVASOL M https//www.nsnlookup.com Amino Acids Injection
6505-33-190-0486 -0909 https//www.nsnlookup.com https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-067-2813
us 6505-01-082-8870 Amino Acids Injection With Electrolytes 6505-33-104-0909 33-190-0486 https/ TRAVASOL M
Amino Acids Injection With Electrolytes es 6505-33-104-0909 6505-33-190-0486 TRAVASOL M https//
004-0615 6505-01-035-6442 6505-01-180-3225 6505-27-041-9904 6505-33-104-0909 6505-33-190-0486 6505-01-067-2813
WITH ELECTROLYTES 3.5 TRAVASOL 3.5% TRAVASOL M 2A6554 NDC00338-0627-04 Managed by United States NSN
/www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-082-8870 Amino Acids Injection With Electrolytes TRAVASOL M
Restrictions 6505-01-067-2813
6505-01-067-2813 is a Amino Acids Injection With Electrolytes that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-01-067-2813
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-067-2813
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-067-2813
- Part Number
- Manufacturer
- Status
- NDC00338-0627-03
- Manufacturer
- 04687 - Baxter Healthcare Corp (Active)
- Primary Buy
- Primary Buy
- F0338062703
- 89875 - Defense Logistics Agency Directorate (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
- TRAVASOL M
- 04687 - Baxter Healthcare Corp (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-067-2813
- Characteristic
- Specifications
- FIIG
- Specifications
- A45100
- Active Medicament Medicinal Strength [AKJA]
- Percentage,W/V Amino Acid Active Ingredient 3.500
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 500.000 Milliliters
- Total Primary Container Quantity [CSCW]
- 12
Management Data 6505-01-067-2813
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- May 1985
- Veterans Administration (VA)
- BT
- Subscribe
- BT
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 500 Ml
- 00000000500ML
- K
Similar Supply Items to 6505-01-067-2813
Freight Information 6505-01-067-2813
6505-01-067-2813 has freight characteristics.. 6505-01-067-2813 has a variance between NMFC and UFC when transported by rail and the description should be consulted.